EX-99.1 2 d793161dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 UNITED STATES BANKRUPTCY COURT EASTERN DISTRICT OF MISSOURI EASTERN DIVISION In re: Case No. 25-40976-357 Chapter 11 CHROME HOLDING CO. (f/k/a 23ANDME HOLDING CO.), et al.,1 Debtors. (Jointly Administered) THIRD AMENDED JOINT PLAN OF CHROME HOLDING CO. AND ITS DEBTOR AFFILIATES PURSUANT TO CHAPTER 11 OF THE BANKRUPTCY CODE PAUL, WEISS, RIFKIND, CARMODY MACDONALD P.C. WHARTON & GARRISON LLP Thomas H. Riske #61838MO Paul M. Basta (admitted pro hac vice) Nathan R. Wallace #74890MO Christopher Hopkins (admitted pro hac vice) Jackson J. Gilkey #73716MO Jessica I. Choi (admitted pro hac vice) 120 S. Central Avenue, Suite 1800 Grace C. Hotz (admitted pro hac vice) St. Louis, Missouri 63105 1285 Avenue of the Americas Telephone: (314) 854-8600 New York, New York 10019 Facsimile: (314) 854-8660 Tele…
Open exhibit ↗Current Report · Items 8.01, 9.01 · 8-K
Chrome Holding Co.
Other Events
Item 8.01 Other Events As previously disclosed, on March 23, 2025, Chrome Holding Co., a Delaware corporation (the “Company”), and certain of its subsidiaries (collectively, the “Filing Subsidiaries” and, together with the Company, the “Debtors”) filed voluntary petitions seeking relief under Chapter 11 of Title 11 of the United States Bankruptcy Code (the “Bankruptcy Code”) in the United States B…
Company context
23andMe is a genetics-led consumer healthcare company empowering a healthier future. For more information, please visit www.23andme.com.
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events
As previously disclosed, on March 23, 2025, Chrome Holding Co., a Delaware corporation (the “Company”), and certain of its subsidiaries (collectively, the “Filing Subsidiaries” and, together with the Company, the “Debtors”) filed voluntary petitions seeking relief under Chapter 11 of Title 11 of the United States Bankruptcy Code (the “Bankruptcy Code”) in the United States Bankruptcy Court (the “Court”) for the Eastern District of Missouri (the “Chapter 11 Cases”).
As previously disclosed, on August 15, 2025, the Debtors filed with the Court the Joint Plan of Chrome Holding Co. and its Debtor Affiliates Pursuant to Chapter 11 of the Bankruptcy Code (as may be amended, modified, or supplemented from time to time, the “Plan”) and a related disclosure statement. Capitalized terms used herein but not defined shall have the meaning given to such terms in the Plan.
On October 1, 2025, the Court entered the Order (I) Approving the Adequacy of the Disclosure Statement, (II) Approving the Solicitation Procedures and Solicitation Package, (III) Scheduling a Confirmation Hearing, (IV) Establishing Procedures for Objecting to the Plan, (V) Establishing the California Claims Determination Procedures, (VI) Approving the Form, Manner, and Sufficiency of Notice of the Confirmation Hearing, (VII) Scheduling Certain Dates Related Thereto, and (VIII) Granting Related Relief (the “Disclosure Statement Order”), which, among other things, allowed the Debtors to solicit votes from Holders of Claims and Interests entitled to vote on the Plan and set November 6, 2025, at 4:00 p.m. (prevailing Central Time) as the deadline to submit votes.
On November 14, 2025, the Debtors filed the Third Amended Joint Plan of Chrome Holding Co. and its Debtor Affiliates. The Plan has been updated to reflect, among other changes, a contemplated modified settlement agreement with the U.S. Data Breach Arbitration Settlement Parties, the removal of the Equity Sale Transaction toggle structure, and certain other technical modifications.
A hearing for the Bankruptcy Court to consider confirmation of the Plan is currently scheduled for November 19, 2025 at 1:30p.m. (prevailing Central Time).
Although the Debtors intend to pursue the objectives and the terms set forth in the Plan, there can be no assurance that the Court will approve the Plan or that the Debtors will be successful in consummating the transactions set forth in the Plan or any similar transaction, on different terms or at all. The Bankruptcy Code does not permit solicitation of acceptances of a chapter 11 plan until the Court enters an order approving the disclosure statement relating to the chapter 11 plan. Accordingly, neither the Debtors’ filing of the Plan, nor this Current Report on Form 8-K, is a solicitation of votes to accept or reject the Plan. Any such solicitation was made pursuant to and in accordance with applicable law, including the Disclosure Statement Order.
Information contained in the Plan is subject to change, whether as a result of amendments or supplements to the Plan, third-party actions, or otherwise, and should not be relied upon by any party. Such amendments and supplements will also be available for review and free of charge online at https://restructuring.ra.kroll.com/23andMe. Such amendments and supplements may be filed with the Court without the filing of an accompanying Current Report on Form 8-K. The documents and other information available via website or elsewhere are not part of this Current Report on Form 8-K and will not be deemed incorporated herein.
A copy of the Plan is attached as Exhibits 99.1, to this Current Report on Form 8-K. The foregoing description of the Plan is a summary only and is qualified in its entirety by reference to the full text of the Plan.
Additional Information on the Chapter 11 Cases
Court filings and information about the Chapter 11 Cases can be found at a website maintained by the Company’s claims agent Kroll at https://restructuring.ra.kroll.com/23andMe, by calling (888) 367-7556, or by sending an email to 23andMeInfo@ra.kroll.com. The documents and other information available via website or elsewhere are not part of this Current Report on Form 8-K and will not be deemed incorporated herein.
Cautionary Note Regarding the Company’s Common Stock
The Company cautions that trading in the Company’s Class A common stock, $0.0001 par value per share (the “Common Stock”) during the pendency of the Chapter 11 Cases is highly speculative and poses substantial risks. Trading prices for the Company’s Common Stock may bear little or no relationship to the actual recovery, if any, by holders of the Common Stock in the Chapter 11 Cases. The Company cannot assure investors of the liquidity of an active trading market, the ability to sell shares of the Common Stock when desired, or the prices that an investor may obtain for the shares of the Common Stock.
Cautionary Note Regarding Forward-Looking Statements
This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, included or incorporated in this document are forward-looking statements. The words “believes,” “anticipates,” “estimates,” “plans,” “expects,” “intends,” “may,” “could,” “should,” “potential,” “likely,” “projects,” “predicts,” “continue,” “will,” “schedule,” and “would” or, in each case, their negative or other variations or comparable terminology, are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are predictions based on the Company’s current expectations and projections about future events and various assumptions. The Company cannot guarantee that it will actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements and you should not place undue reliance on the Company’s forward-looking statements. These forward-looking statements involve a number of risks, uncertainties (many of which are beyond the control of the Company), or other assumptions that may cause actual results or performance to differ materially from those expressed or implied by these forward-looking statements, which could include the following: risks and uncertainties relating to the Chapter 11 Cases, including but not limited to, the Company’s ability to obtain Court approval with respect to motions in the Chapter 11 Cases, the effects of the Chapter 11 Cases on the Company and on the interests of various constituents, Court rulings in the Chapter 11 Cases (including whether the Plan will be confirmed by the Court and whether the Effective Date of the Plan occurs) and the outcome of the Chapter 11 Cases in general, the length of time the Company will operate under the Chapter 11 Cases, risks associated with any third-party motions in the Chapter 11 Cases, the adverse effects of the Chapter 11 Cases on the Company’s liquidity or results of operations and increased legal and other professional costs necessary to execute the Company’s Chapter 11 Cases; trading price and volatility of the Common Stock; and the continuation of trading of the Common Stock on the OTC Pink Market, including whether broker-dealers will continue to provide public quotes of the Common Stock on the OTC Pink Market and whether the trading volume of the Common Stock will be sufficient to provide for an efficient trading market. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), including under Item 1A, “Risk Factors” in the Company’s most recent Annual Report on Form 10-K, as filed with the SEC, and as revised and updated by the Company’s Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The statements made herein are made as of the date of this document and, except as may be required by law, the Company undertakes no obligation to update them, whether as a result of new information, developments, or otherwise.